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ABSTRACT 
The work investigated the design and evaluation of microspheres of Nitazoxanide by Ionotropic gelation technique method. 32 
Factorial designs were used and concentration of polymer carbopol-934 (X1) and Ethyl cellulose (X2) were selected as the 
independent variables. The surface morphology study by SEM indicated that microspheres were spherical with smooth surface. 
There was no interaction between the drug and polymers, as studied by FTIR study. The prepared microspheres were characterized 
by entrapment efficiency, particle size micromeritic properties. It was observed that on increasing polymer concentration of 
formulations, % yield, the entrapment efficiency and particle size were increased whereas % drug release decreased. The In Vitro 
release study was done using U.S.P. dissolution rate basket type apparatus in phosphate buffer pH 7.4 for 10 hr. It shows that on 
increasing polymer concentration the drug release of all formulations was gradually decreased. In Vitro mucoadhesion study depicts 
that as the polymer concentration increased, mucoadhesive nature of the formulation was also increased. The microspheres of NTZ 
(formulation F9) showed best results due to highest drug entrapment efficiency (85.50%), and percentage drug release after 10.0 hr. 
was 50.25%. The rate of release followed First order kinetics. The microspheres exhibits good mucoadhesive properties in  in- vitro 
wash-off test at pH 7.4 (Intestinal pH) than pH 1.2 (gastric pH),because the drug was completely absorbed in Gastrointestinal tract, 
Therefore, it can be concluded that Nitazoxanide Loaded algino-carbopol-934 microspheres can be formulated for sustained drug 
delivery of Nitazoxanide used in Chronic Hipatitis-C. 
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Microspheres are small spherical particles, with 
diameters in the micrometer range (typically 1 μm to 
1000 μm), manufactured from natural or synthetic 
polymers. Microspheres have numerous applications 
depending on what material they are constructed of and 
what size they are. Microsphere play numerous 
applications in biomedical sciences from diagnostic to 




imaging topical delivery, vaccine delivery
 
and delivery 
of Monoclonal antibodies mediated microspheres 
targeting.
1-10 
Nitazoxanide (NTZ) chemically [2-[(5-nitro-1, 3-thiazol-
2-yl) carbamoyl] phenyl] acetate, which is a newly 
approved antiprotozoal drug used in the treatment of 
cryptosporidiosis in immune comprised patients 
including those with AIDS or HIV infection
7-10
. NTZ is 
rapidly absorbed and converted to active metabolite 
tizoxanide, which inhibit Pyruvate ferredoxin 
oxidoreductase pathway. Nitazoxanide appears to have 
activity against metronidazole (MTZ) resistant protozoal 
strains and well tolerated. 
It is indicated for amoebiasis, helminthiasis giardiasis, 
fascioliasis, trichomoniasis and cryptosporidiosis
10-14
. 
The anti-protozoal activity of nitazoxanide is believed to 
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be due to interference with the pyruvate:ferredoxin 
oxidoreductase (PFOR) enzyme dependent electron 
transfer reaction which is essential to anaerobic energy 
metabolism.
15-20 
It has also been shown to have activity 
against influenza A virus. A survey of literature reveals 
that very few method & solvents were available for the 
estimation of Nitazoxanide. 
MATERIALS AND METHODS 
Materials 
Nitazoxanide was obtained from Alembic 
Pharmaceutical Ltd. Vadodara India. Carbopol-934 was 
obtained from Manish Pharma, Baddi, India. Sodium 
alginate, ethyl cellulose, calcium chloride, di sodium 
hydrogen phosphate, and methanol   were obtain from S 
.D. Fine chemicals. All the other chemicals and reagents 
were of analytical grade. Drug and polymer were 
evaluated spectometrically for purity, identity.   
Method  
In brief weight quantity of sodium alginate (3%) and 
ethyl cellulose were dissolved separately in distilled 
water (100mL) and ethanol (5mL). Then solution of 
ethanol was mixed in previously prepared sodium 
alginate solution. In separate beaker weight quantity of 
drug and Corbopol- 934 were dissolved in methanol and 
added to above solution with continuous stirring. The 
prepared mixture was dropped into CaCl2 (3% w/v) 
solution using 26 G Syringe needle. Microspheres were 
obtained, filtered, washed with distilled water, air-dried 
at room temperature and stored in desiccators.
20-27 




full factorial design, 2-factor, 3-level. 






Crosslinking agent CaCl2 
%w/v 
F1 30 60 60 3 3 
F2 30 30 60 3 3 
F3 30 90 60 3 3 
F4 30 60 30 3 3 
F5 30 30 30 3 3 
F6 30 90 30 3 3 
F7 30 60 90 3 3 
F8 30 30 90 3 3 
F9 30 90 90 3 3 
 
Particle size  
Particle size of Nitazoxanide microspheres were 
measured by optical microscopy. The values obtained 
were from triplicate experiments and expressed as mean 
± standard deviation 
28-31
. 
Microsphere recovery, drug content and entrapment 
efficiency 
Nitazoxanide Microsphere recovery (%) was calculated 
by weighing lyophilized Microsphere accurately, and 
using following formula   
                      
                            
                      
×100 
Drug content study 
The drug content of microsphere was determined by 
spectrophotometrically at 414.4 nm (UV-2201, 
Systonics). Each determination was made in triplicate. 
32-35
 
Drug content were calculated by using following 
formula  
Drug Content = Conc. × dilution factor × volume/1000 
Morphological Examination (SEM)  
A texture of surface for prepared microspheres was done 
by taking Scanning electron photomicrographs. The 
sample was spread on stub and coated for 120 Swith a 
layer of gold using a sputter coater. Afterwards, the stub 
containing the sample was placed in the scanning 
electron microscope (ZEISS) chamber at the 




X-ray Powder Diffractometry (XRD) 
Diffraction patterns of physical mixtures; drug and 
polymers were recorded with a PW 3040/60 X’ Pert 
PRO, Netherland. A voltage of 40 KV and a current of 
45 mA for the generator were used, with Cu as the tube 
anode material. The solids were exposed to Cu-Kα 
radiation (α1=1.54060 Å and α2=1.54439 Å, with a 
α1/α2 ratio of 0.5), over a range of 2θ angles from 00C 
to 60
0
C, at an angular speed of 3
0 (2θ) per minute. 
Differential scanning calorimetry (DSC)  
DSC provides information about all physical properties 
of sample as Crystalline or Amorphous nature and 




In-vitro mucoadhesion study  
The mucoadhesive property of microspheres was 
evaluated by an in vitro adhesion testing method known 
as wash-off method by using freshly excised piece of 
intestinal mucosa (2 x 2 cm) from goat, glass slides (3 x 
1 inch) and USP tablet disintegrating test machine 
41-43
. 
In brief microsphere were spread on tissue specimen 
attached with glass slide and hung it on to the arm of 
USP apparatus then assembly started.   At the end of one 
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hour no of number of microspheres still adhering to 
tissue was calculated as following.  
              
                             
                             
     
In-vitro drug distribution study  
In-vitro drug distribution study of Nitazoxanide 
microsphere were calculated spectometrically by using 
basket dissolution apparatus
44-50
.   
Stability of Mucoadhessive microspheres 
Stability studies were performed according to ICH and 
WHO guidelines. Optimized microspheres were packed 
in an aluminum foil and kept in petridish at room 
temperature (37
o
C) and in Humidity chamber at 40
o
C, 
75% RH for a period of 28 days
51-55
. At the end of 
studies, Microspheres were evaluated for physical 
properties, in- vitro drug release and drug content. 
RESULTS AND DISCUSSION 
Drug Identification Tests 
Melting Point Determination (Capillary Method) 
Melting point of the drug was determined using 
capillary method by the melting point apparatus. Drug 
was filled in the capillary after sealing the capillary from 
one end and then the sample was placed in the apparatus 
along with the thermometer and when the drug melted 
its temperature is recorded. Melting point of the drug 





UV Spectrophotometric Study 
The λmax was determined by preparing the 25 ml 
Actonitrile & water (9:1) solution of 2µg/ml-10µg/ml 
and further the sample was scanned at the range of 400-
200nm. It was observed that the maximum absorbance 
was seen at 238.3nm, (using UV2201Pharma Spec 
Systronics) which was regarded as the λmax of the drug 
Nitazoxanide . The λmax of the drug Nitazoxanide in 50 
ml  Methanol:water (50:50) mixture was found to be 
328 nm as  & in pH 7.4 phosphate buffer was found to 
be 414.4 nm. 
  
.  
Figure 1: λmax Scan for the drug at 238.3 nm in 25 ml Acetonitrile & water Solution (9:1) 
 
Figure  2: λmax Scan for the drug at 328 nm in methanol:water (50:50) mixture 
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Figure 3:  λmax Scan for the drug at 414.4 nm in pH 7.4 phosphate buffer Solution 
 
IR Spectral Analysis     
Infrared (IR) spectroscopy was performed using FTIR 
Spectrophotometer (Shimadzu) the spectrum was 
recorded in the wavelength region of 4000 to 600 cm
−1
.  
Pellets for the spectra were prepared using KBr 
hydraulic press, by dispersing a sample of drug in KBr 
and compressed into discs. The pellet was then placed in 
the FTIR and the spectrum was obtain and its 
interpretation is shown below. 
 
 
Figure 4: IR spectra of pure drug Nitazoxanide 
 
Table 2: Interpretation of IR spectra of pure drug Nitazoxanide 
S.No. Functional Group Range (cm
-1
) Observed Frequency (cm
-1
) 




2 Nitro group 1500-1350 1527.69 
3 =CH stretch 2960-2850 3061 
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Compatibility Studies between the Drug and 
Polymer  
 For the drug excipients compatibility studies, the 
sample were kept at 40
0
C & 75 % RH for 4 weeks, 
sample withdrawn, carried out and evaluated. For the 
result of compatibility studies that there was no change 
in physical appearance and optimized formulation, no 
incompatibility in drug alone or with excipients as same 
peaks were observe. In IR Spectra of physical mixture & 
optimized formulation are compared to Nitazoxanide 
drug which shows that there were no interaction 
between drug and polymer as shown in  Figure 5 & 
Figure 6 . 
 
 
Figure 5:IR spectra of microspheres of Physical mixture of of Drug Nitazoxanide and Polymer carbopol-934 
 
Figure 6 :IR spectra of microspheres of optimized formulation of Nitazoxanide 
 
Table 3: Interpretation of IR spectra of Physical mixture of of Drug Nitazoxanide and IR spectra of 
microspheres of optimized formulation of Nitazoxanide  
S.No. Functional Group Range (cm
-1
) Observed frequency (cm
-1
)  
1 -OH group 3000-3700 3700.1 
2 Carbonyl group 1690-1760 1720 
3 Nitro group 1330-1640  1622 
4 Amide group 3000-3700 3405.5 
 
Evaluation of Microspheres 
Micrometric Properties of microspheres 
Particle Size Analysis 
The optical microscopy method was used to determine 
the particle size of prepared microspheres, in this 
method, the diameter of 100 microspheres was 
determined and from it the mean diameter was 
calculated. All readings were taken in triplicate. 
The mean particle size was found to be 580.75 ±6.87μm 
to 729.94 ±10.12μm  
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Bulk density 











Table 4: Characterization of mucoadhesive microspheres of Nitazoxanide 
F.Code BulK  
Density 
Tapped  
  density 
%Carr’s 
   index 
Hausner’s  
  Ratio 




F1 0.398±0.01 0.422±0.02 5.68±0.10 1.060±0.01 14.06 ± 1.20 
F2 0.435±0.02 0.464±0.02 6.25±0.15 1.167±0.01 21.88±0.15 
F3 0.411±0.01 0.434±0.02 5.30±0.12 1.056±0.01 12.86±0.14 
F4 0.510±0.03 0.546±0.03 6.59±0.09 1.071±0.02 14.25±0.15 
F5 0.468±0.02 0.524±0.12 10.68±0.07 1.119±0.03 14.35±0.15 
F6 0.407±0.02 0.442±0.13 7.92±0.13 1.086±0.02 15.89±0.19 
F7 0.528±0.03 0.563±0.12 6.21±0.12 1.066±0.02 25.32±0.11 
F8 0.635±0.03 0.658±0.13 3.49±0.13 1.036±0.09 24.02±0.14 
F9 0.571±0.02 0.587±.011 2.73±0.11 1.028±0.01 20.45±0.10 
 
*F5 formulation showed the best flow property and flow of all other formulations were excellent this showed that 
particles were decreases their crystallinity. 





Actual drug content 
(mg) ± S.D. 
%Drug 
entrapment ± S.D. 
Average particle 
size ± S.D. 
F1 83.55±1.14 30 22.10±0.71 73.66±1.67 642.65±5.41 
F2 80.45 ±2.05 30 21.28±0.74 72.66±2.10 585.45±4.10 
F3 87.22±2.01 30 23.15±0.68 77.16±1.96 702.56±5.69 
F4 81.61±2.70 30 21.65±0.35 72.16±1.85 642.7±5.13 
F5 76.19±1.53 30 20.16±0.25 67.20±1.04 580.75±6.87 
F6 85.77±2.93 30 22.69±0.13 75.63±1.25 680.2±6.17 
F7 87.09±1.40 30 24.46±0.15 81.53±1.09 648.85±5.51 
F8 86.88±1.91 30 22.91±0.08 76.36±1.64  590.62±6.40 
F9 90.22±1.51 30 25.65±0.10 85.50±1.54 729.94±10.12 
 
F9 Formulation showed best result due to high % drug 
entrapment & high % Yield 
Because in F9 formulation higher polymer 
concentration. 
SEM  
The surface morphology of mucoadhesive microspheres 
was examined by Scanning electron microscopy (SEM) 
,the SEM showed that microspheres obtained from 
optimized formulation was spherical and smooth surface  
at two different magnifications (10 µm & 50 µm) as 
shown in Fig.7. 
 
  
(A): SEM Photograph (10 μm) of formulation (F9 (B): SEM Photograph (50 μm) of formulation (F9) 
Figure 7: SEM micrograph of optimized Formulation of Nitazoxanide microspheres (F9 under two different 
magnifications (A & B 10μm & 50μm). 
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Powder X-Ray Diffraction Study (PXRD) of Drug 
and Formulation 
The presence of several Large peaks in the PXRD of 
Pure drug Nitazoxanide at a diffraction angle of 6.50º, 
25.02º, 31.50º and 46.25º were obtained, but in 
Nitazoxanide microspheres formulation small peaks 
were obtained at diffraction angle 31.53 º, 
44.84º&56.85º were obtained revealed that the drug is 
present as a crystalline form and converted into 
amorphous form as shown in figure. 
 
 
Figure 8: Sample- XRD of NTZ pure drug 
 
Figure 9: Sample: XRD optimized formulation (F9) of NTZ 
Differential scanning colorimetery (DSC)  
DSC provides information about all physical properties 
of sample as Crystalline or Amorphous nature and 
demonstrates the possible interaction between Drug and 
other Polymers. The thermal behavior of Nitazoxanide 
and physical mixture of drug & polymers are shown in 
(Figure No. 10 and 11 ), according to thermogram, 
Nitazoxanide produced sharp Endothermic peak at 
197.5
0
C which conformed crystalline form of the drug. 
DSC curves of the drug and Physical mixture of drug & 
polymers   Exhibited an Endothermic peaks at 201.5
0
C, 
which has been attributed to the evaporation of water. 
The thermogram of the physical mixture of Drug and 
Polymers showed that there was no interaction between 
drug and polymers. 
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Figure 10: DSC Spectra of pure drug Nitazoxanide 
 
Figure 11: DSC Spectra for physical mixture of pure 
drug Nitazoxanide +Carbopol 934+Ethyl Cellulose 
+Sodium Alginate 
Mucoadhesion property of optimized formulation of 
microspheres of Nitazoxanide 
The mucoadhesive property of microspheres was 
evaluated by an in vitro adhesion testing method known 
as wash-off method in phosphate buffer pH 7.4. 
Table 6: % Mucoadhesion of optimized formulation 
of microspheres of Nitazoxanide 




F1 84±   1.45 65.81±1.42 
F2 90±   1.24 73.31±1.35 
F3 70±   1.35 56.81±1.21 
F4 85±   1.65 75.18±1.12 
F5 45±    1.75 80.06±1.15 
F6 78±  1.85 68.44±1.28 
F7 90±   1.65 58.31±1.45 
F8 93±     1.75 69.94±1.38 
F9 95±     1.23 50.25±1.21 
 
Invitro Studies 
The prepared microspheres of Nitazoxanide were placed 
in each of the six basket dissolution apparatus. The 
assembly was maintained at a temperature of 37
0
C in 
phosphate buffer, pH 7.4. Samples were withdrawn at 
definite time intervals and replaced by equal volume of 
fresh medium. The absorbance of samples was measured 
from UV spectrophotometer. Concentration and % 




Dissolution profile revealed that after 10 hr.  
Formulation F1-F9 released 65.81%, 73.31%, 56.81%, 
75.18%, 80.06%, 68.44%, 58.31%, 69.94% and 50.25% 
drug respectively. The reason behind the lesser drug 
release of F3, F7, F8 and F9 in comparison to F1, F2, 
F4, F5, and F6 might be the use of high concentration of 
Carbopol-934, Ethyl cellulose. 
Formulations (F9) showed lesser drug release than (F5) 
because higher the polymer concentration lower the drug 
release where as in case of F5 formulation the polymer 
conc. was less so drug release is higher so F9 
Formulation showed best result for sustained release.
 
 
Figure 12: In vitro release profile of Microspheres of Nitazoxanide. 
Statistical Analysis 
Factorial design was used to select the factors displaying 
the most effects on the microspheres properties. 3
2 
full 
factorial design, 2-factor, 3-level.The two obtained 
factors were carbopol-934 conc. (X1) & ethyl cellulose 
conc. (X2) which is in dependent variables & % 
mucoadhesion, in vitro release, % drug entrapment 
which  is dependent variables. 
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Table 7:Two- way ANOVA of Microspheres of Nitazoxanide 
Source of Variation SS Df MS F P value    Prob.> F 
Model 858.76 3 286.25 285.18 0.0128 Significant 
A-A 300.31 1 300.31 21.64 0.0288 
B-B 729.59 1 729.59 6.43 0.0022 
A-B 180.37 1 180.37 6.75 0.0749 
Pure error 400.37 9 44.49 17.82  
Cor total 1259.13 12  4.05  
 
The Model F-value of 6.43 implies the model is 
significant.  There is only 
a 1.28% chance that a "Model F-Value" this large could 
occur due to noise. Values of "Prob > F" less than 
0.0500 indicate model terms are significant.   
Stability studies  
Before storage- Drug Content- 25.65±0.10, % 
Cummulative release- 50.25±0.12 
 
Table 8: Stability Analysis of Optimized Formulation F9 
Date in- 04/04/2014, Storage Condition- 40
o
C, 75% RH, Packaging- Glass Vials 
Sampling 
interval 
One week  Two week  Three week Four week 




10/04/20114 17/04/2014 24/04/2014 01/05/2014 
Drug content 
(mg) 




50.02±0.13 49.97± 0.11 48.88 ±0.10 47.99 ±0.12 
 
CONCLUSION 
Nitazoxanide loaded Alginate microspheres were 
successfully prepared by Ionotropic gelation technique. 
The micromeritic study of microspheres suggests that on 
formulation of microsphere from pure drug the flow 
behavior of drug was improved. From the SEM of 
microspheres it was evident that the microspheres were 
spherical in shape with smooth surface. The mean 
particle size of microsphere was found in the range of 
580.75µm to 729.94µm. A systemic study using a 3
2 
Factorial design was done. The independent variables 
had significant influence on dependent variables. 
Concentration of polymer ratio influence drug release 
profile & entrapment efficiency of microspheres. As the 
polymer concentration increases, % drug release 
decreases whereas the entrapment efficiency increases. 
All the formulation followed first order release kinetics. 
The Formulation F9 showed maximum entrapment 
efficiency of 85.50% and 50.25% of control drug release 
up to 10hr. The microspheres exhibited good 
mucoadhesive property in the in vitro wash off test and 
also showed high percentage drug entrapment 
efficiency. Formulation F9 microspheres were selected 
as best formulation for preparation of sustained drug 
delivery system. The data obtained thus suggest that 
mucoadhesive microspheres can be successfully 
designed for sustained delivery of Nitazoxanide and to 
improve patient compliance. 
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